ASTS
AST SpaceMobile, Inc.
ASTS trails on the overall score without a compensating advantage in the available component scores.
MXL
MaxLinear, Inc.
MXL has the edge over ASTS overall, supported by stronger fundamentals.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MXL Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Under pressure | |
| Stable |
MXL's revenue is currently strong, and its profitability and balance sheet are stable, but its cash flow is under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
MXL PE Valuation
MXL has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
MXL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for MXL, with profitability improving.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
MXL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.06 | — |
| Q3 2026 | -$0.37 | +$1.72 |
| Q2 2026 | -$1.19 | +$1.28 |
| Q1 2026 | -$1.52 | +$1.11 |
| Q4 2025 | -$1.58 | +$1.35 |
| Q3 2025 | -$2.09 | +$0.65 |
| Q2 2025 | -$2.47 | -$0.14 |
| Q1 2025 | -$2.63 | -$0.72 |
| Q4 2024 | -$2.93 | -$2.02 |
MXL has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over MXL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
MXL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $218.1M | +72% |
| Q2 2026 | $168.8M | +55% |
| Q1 2026 | $137.2M | +43% |
| Q4 2025 | $136.4M | +48% |
| Q3 2025 | $126.5M | +56% |
| Q2 2025 | $108.8M | +18% |
| Q1 2025 | $95.9M | +0.7% |
| Q4 2024 | $92.2M | -26% |
MXL's revenue is recovering but still below its 2022 peak: $218M last quarter, up 72% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +47 points |
| Q2 2026 | -2.5% | +20 points |
| Q1 2026 | -13% | +36 points |
| Q4 2025 | -11% | +34 points |
| Q3 2025 | -33% | +50 points |
| Q2 2025 | -23% | +22 points |
| Q1 2025 | -48% | +30 points |
| Q4 2024 | -45% | -11 points |
MXL has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
MXL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$19.5M | -544% |
| Q2 2026 | $2.5M | -73% |
| Q1 2026 | -$10.3M | +$3.1M |
| Q4 2025 | $6.7M | +$36.7M |
| Q3 2025 | $4.4M | +$39.3M |
| Q2 2025 | $9.3M | +$15M |
| Q1 2025 | -$13.4M | -276% |
| Q4 2024 | -$30M | -$12.2M |
MXL has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MXL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.6x | Moderate |
| Q4 2023 | -2.0x | Net Cash |
| Q3 2023 | -0.6x | Net Cash |
| Q2 2023 | -0.5x | Net Cash |
| Q1 2023 | -0.4x | Net Cash |
| Q4 2022 | -0.3x | Net Cash |
| Q3 2022 | -0.0x | Net Cash |
| Q2 2022 | 0.2x | Very low |
MXL's net debt is about 2.6 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
MXL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.8 | Neutral |
| Stochastic | 16.3 | Oversold |
MXL's weekly RSI is 46 (neutral) and its Stochastic is 16 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
MXL PE vs Technology Sector
| Metric | MXL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
MXL has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
MXL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $75.8 | 22% below |
| 20 week MA | $75.4 | 22% below |
| 50 week MA | $55.0 | 7.2% above |
| 100 week MA | $35.0 | 69% above |
| 200 week MA | $28.7 | 106% above |
MXL has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
MXL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.4 | $36.7 | +71% |
| 2021 | $36.7 | $74.1 | +102% |
| 2022 | $74.1 | $33.9 | -54% |
| 2023 | $33.9 | $23.8 | -30% |
| 2024 | $23.8 | $20.5 | -14% |
| 2025 | $20.5 | $17.7 | -14% |
| 2026 YTD | $17.7 | $59.0 | +233% |
MXL has the edge over ASTS on returns for 2026, with the stronger performance.